Skip to main content
OKUR filings

Corporate insider profile

Nicholas A Saccomano Filing Activity

Latest reported as President and CEO of OnKure Therapeutics, Inc. (OKUR).

Purchase filings
0
Reported companies
1
Net open-market value
-$378.08
Latest transaction
Jun 22, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 22, 2026OnKure Therapeutics, Inc. (OKUR)President and CEOSale86$4.40$378.08